David Sartori1, Tamorah Lewis2, Autumn Breaud1, William Clarke3. 1. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: wclarke@jhmi.edu.
Abstract
OBJECTIVES: Development and validation of a selective, robust high-performance liquid chromatography-tandem mass spectrometric (HPLC/MS-MS) method for the quantification of morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine in human serum. DESIGN AND METHODS: Drug-free human serum samples spiked with morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine were prepared by protein precipitation using methanol containing the internal standards. Samples were injected onto a Thermo Scientific AccuCore PFP column for chromatographic separation. Detection was achieved using a Thermo Scientific TSQ Vantage mass spectrometer. Assay validation followed the new Clinical and Laboratory Standards Institute (CLSI) C62-A guidelines. RESULTS: The analytical measuring range for all analytes was determined to be 5 to 1000 ng/mL. Intra- and inter-assay precision for three quality control levels were ≤ 7.0% and ≤ 13.5%, respectively. Carryover, stability, linearity, matrix effects, extraction and processing efficiency and method comparison characteristics were acceptable relative to the CLSI C62 guidelines. CONCLUSION: The validation of this HPLC-MS/MS method demonstrated a robust and rapid assay for the quantification of morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine.
OBJECTIVES: Development and validation of a selective, robust high-performance liquid chromatography-tandem mass spectrometric (HPLC/MS-MS) method for the quantification of morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine in human serum. DESIGN AND METHODS: Drug-free human serum samples spiked with morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine were prepared by protein precipitation using methanol containing the internal standards. Samples were injected onto a Thermo Scientific AccuCore PFP column for chromatographic separation. Detection was achieved using a Thermo Scientific TSQ Vantage mass spectrometer. Assay validation followed the new Clinical and Laboratory Standards Institute (CLSI) C62-A guidelines. RESULTS: The analytical measuring range for all analytes was determined to be 5 to 1000 ng/mL. Intra- and inter-assay precision for three quality control levels were ≤ 7.0% and ≤ 13.5%, respectively. Carryover, stability, linearity, matrix effects, extraction and processing efficiency and method comparison characteristics were acceptable relative to the CLSI C62 guidelines. CONCLUSION: The validation of this HPLC-MS/MS method demonstrated a robust and rapid assay for the quantification of morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine.
Authors: Simin O Mashayekhi; Mohammadreza Ghandforoush-Sattari; Philip A Routledge; Richard D W Hain Journal: Biopharm Drug Dispos Date: 2009-04 Impact factor: 1.627
Authors: Ajay D Wasan; Edward Michna; David Janfaza; Shelly Greenfield; Christian J Teter; Robert N Jamison Journal: Pain Med Date: 2007-08-28 Impact factor: 3.750
Authors: Nicholas M Dalesio; Carlton K K Lee; Craig W Hendrix; Nikole Kerns; Aaron Hsu; William Clarke; Joseph M Collaco; Sharon McGrath-Morrow; Myron Yaster; Robert H Brown; Alan R Schwartz Journal: Anesth Analg Date: 2020-09 Impact factor: 6.627
Authors: Tao Liu; Tamorah R Lewis; Jason N Moore; Walter K Kraft; Estelle B Gauda; David Sartori; David E Moody; Jogarao V S Gobburu; Vijay Ivaturi Journal: CPT Pharmacometrics Syst Pharmacol Date: 2019-05-10